Cargando…

Monitoring and Characterization of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Japan, 2009–2010

To monitor and characterize oseltamivir-resistant (OR) pandemic (H1N1) 2009 virus with the H275Y mutation, we analyzed 4,307 clinical specimens from Japan by neuraminidase (NA) sequencing or inhibition assay; 61 OR pandemic (H1N1) 2009 viruses were detected. NA inhibition assay and M2 sequencing ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ujike, Makoto, Ejima, Miho, Anraku, Akane, Shimabukuro, Kozue, Obuchi, Masatsugu, Kishida, Noriko, Hong, Xu, Takashita, Emi, Fujisaki, Seiichiro, Yamashita, Kazuyo, Horikawa, Hiroshi, Kato, Yumiko, Oguchi, Akio, Fujita, Nobuyuki, Tashiro, Masato, Odagiri, Takato
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166015/ https://www.ncbi.nlm.nih.gov/pubmed/21392439 http://dx.doi.org/10.3201/eid1703.101188

Ejemplares similares

Oseltamivir-Resistant Influenza Viruses A (H1N1) during 2007–2009 Influenza Seasons, Japan
por: Ujike, Makoto, et al.
Publicado: (2010)

Molecular Evolutionary Analysis of the Influenza A(H1N1)pdm, May–September, 2009: Temporal and Spatial Spreading Profile of the Viruses in Japan
por: Shiino, Teiichiro, et al.
Publicado: (2010)

A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir
por: Matsuzaki, Yoko, et al.
Publicado: (2010)

Characterization of neuraminidase inhibitor‐resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post‐pandemic periods in Japan
por: Takashita, Emi, et al.
Publicado: (2013)

Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil
por: Takashita, Emi, et al.
Publicado: (2018)

Host Adaptation and the Alteration of Viral Properties of the First Influenza A/H1N1pdm09 Virus Isolated in Japan
por: Ainai, Akira, et al.
Publicado: (2015)

Rapid detection of an I38T amino acid substitution in influenza polymerase acidic subunit associated with reduced susceptibility to baloxavir marboxil
por: Nakauchi, Mina, et al.
Publicado: (2020)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infection in England and Scotland, 2009–2010
por: Calatayud, Laurence, et al.
Publicado: (2011)

Possible Transmission of Pandemic (HIN1) 2009 Virus with Oseltamivir Resistance
por: Mandelboim, Michal, et al.
Publicado: (2010)

Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018
por: Takashita, Emi, et al.
Publicado: (2019)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Mexico
por: Ramirez-Gonzalez, José Ernesto, et al.
Publicado: (2011)

Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir
por: Reddy, David
Publicado: (2010)

In Vitro Characterization of Multidrug-Resistant Influenza A(H1N1)pdm09 Viruses Carrying a Dual Neuraminidase Mutation Isolated from Immunocompromised Patients
por: Takashita, Emi, et al.
Publicado: (2020)

Detection of Pandemic (H1N1) 2009 Virus in Patients Treated with Oseltamivir
por: Boutolleau, David, et al.
Publicado: (2010)

Oseltamivir-resistant pandemic (H1N1)2009 in Yemen - case report
por: Thabet, Ahmed AK, et al.
Publicado: (2010)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Treated with Nebulized Zanamivir
por: Da Dalt, Liviana, et al.
Publicado: (2010)

Pandemic (H1N1) 2009 and Oseltamivir Resistance in Hematology/Oncology Patients
por: Wolfe, Cameron, et al.
Publicado: (2010)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, South Korea
por: Yi, Hwajung, et al.
Publicado: (2010)

Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019
por: Takashita, Emi, et al.
Publicado: (2019)

Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019
por: Takashita, Emi, et al.
Publicado: (2019)

Oseltamivir-Resistant Pandemic (H1N1) 2009 in Patient with Impaired Immune System
por: Hill-Cawthorne, Grant A., et al.
Publicado: (2010)

Characteristics of Patients with Oseltamivir-Resistant Pandemic (H1N1) 2009, United States
por: Graitcer, Samuel B., et al.
Publicado: (2011)

Community-acquired Oseltamivir-Resistant Pandemic (H1N1) 2009 in Child, Israel
por: Zonis, Zeev, et al.
Publicado: (2010)

Characterization of Oseltamivir-Resistant 2009 H1N1 Pandemic Influenza A Viruses
por: Kiso, Maki, et al.
Publicado: (2010)

Oseltamivir‐resistant influenza A 2009 H1N1 virus in immunocompromised patients
por: Couturier, Brianne A., et al.
Publicado: (2010)

Characterization of influenza A(H1N1)pdm09 viruses isolated from Nepalese and Indian outbreak patients in early 2015
por: Nakamura, Kazuya, et al.
Publicado: (2017)

Emergence of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus within 48 Hours
por: Inoue, Masafumi, et al.
Publicado: (2010)

Occurrence and characterization of oseltamivir-resistant influenza virus in children between 2007-2008 and 2008-2009 seasons
por: Kim, Seoung Geun, et al.
Publicado: (2013)

Oseltamivir use and outcomes during the 2009 influenza A H1N1 pandemic in Taiwan
por: Liu, Chia-Hung, et al.
Publicado: (2013)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infections, United States, 2010–11
por: Storms, Aaron D., et al.
Publicado: (2012)

Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009
por: Lee, Vernon J, et al.
Publicado: (2010)

Oseltamivir-Resistant Influenza A Pandemic (H1N1) 2009 Virus, Hong Kong, China
por: Chen, Honglin, et al.
Publicado: (2009)

Comparisons of oseltamivir‐resistant (H275Y) and concurrent oseltamivir‐susceptible seasonal influenza A(H1N1) virus infections in hospitalized adults, 2008–2009
por: Chan, Martin C. W., et al.
Publicado: (2012)

Prevalence of Oseltamivir-Resistant 2009 H1N1 Influenza Virus among Patients with Pandemic 2009 H1N1 Influenza infection in NRITLD, Tehran, Iran
por: Moradi, Ahmadreza, et al.
Publicado: (2011)

Susceptibility of influenza A(H1N1)/pdm2009, seasonal A(H3N2) and B viruses to Oseltamivir in Guangdong, China between 2009 and 2014
por: Liu, Shan-shan, et al.
Publicado: (2017)

TMPRSS2 Independency for Haemagglutinin Cleavage In Vivo Differentiates Influenza B Virus from Influenza A Virus
por: Sakai, Kouji, et al.
Publicado: (2016)

Oseltamivir Resistance in Adult Oncology and Hematology Patients Infected with Pandemic (H1N1) 2009 Virus, Australia
por: Tramontana, Adrian R., et al.
Publicado: (2010)

First Fatal Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Case in an Adult in Korea
por: Hong, Seung-Dok, et al.
Publicado: (2011)

Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009
por: Goldstein, Edward, et al.
Publicado: (2010)

Oseltamivir–Resistant Pandemic H1N1/2009 Influenza Virus Possesses Lower Transmissibility and Fitness in Ferrets
por: Duan, Susu, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vghtknkvh4g26c0hu9ckl8ndju